93 related articles for article (PubMed ID: 12870516)
1. HIV preventive vaccine research and access to anti-retrovirals.
Landman WA; Schuklenk U
Dev World Bioeth; 2001 Nov; 1(2):iii-v. PubMed ID: 12870516
[No Abstract] [Full Text] [Related]
2. Human experimentation in developing countries: improving international practices by identifying vulnerable populations and allocating fair benefits.
Farrell K
J Health Care Law Policy; 2006; 9(1):136-61. PubMed ID: 17165228
[No Abstract] [Full Text] [Related]
3. The shame of medical research.
Rothman DJ
New York Rev Books; 2000 Nov; 47(19):60-4. PubMed ID: 11808621
[No Abstract] [Full Text] [Related]
4. Testing therapies less effective than the best current standard: ethical beliefs in an international sample of researchers.
Kent DM; Mwamburi M; Cash RA; Rabin TL; Bennish ML
Am J Bioeth; 2003; 3(2):W11. PubMed ID: 14635629
[TBL] [Abstract][Full Text] [Related]
5. Access to AIDS treatment in developing countries: a global issue of equity and human rights.
Thomas J
AIDS Anal Asia; 1998 Mar; 4(2):2-4. PubMed ID: 11657713
[No Abstract] [Full Text] [Related]
6. AIDS researchers, activists to face off over drug studies.
Chase M
Wall St J (East Ed); 2005 May; ():B7. PubMed ID: 16134271
[No Abstract] [Full Text] [Related]
7. Good enough to use for research, but not good enough to benefit from the results of that research: are the clinical HIV vaccine trials in Africa unjust?
Yearby R
De Paul Law Rev; 2004; 53(3):1127-54. PubMed ID: 16200692
[No Abstract] [Full Text] [Related]
8. Controversial AIDS vaccine to be tested in China.
Brown P
New Sci; 1993 May; 138(1875):7. PubMed ID: 11656245
[No Abstract] [Full Text] [Related]
9. Bush declines to support drug companies' line on AIDS profits.
Dickson D
Nature; 2001 Mar; 410(6824):3. PubMed ID: 11241998
[No Abstract] [Full Text] [Related]
10. Research on hire.
Gupta AS
Issues Med Ethics; 2001; 9(4):111-3. PubMed ID: 16334912
[No Abstract] [Full Text] [Related]
11. Ethical considerations in AIDS vaccine trials.
Mehendale S
Issues Med Ethics; 2000; 8(1):13-5. PubMed ID: 16323332
[No Abstract] [Full Text] [Related]
12. Vulnerability, scientific research and AIDS.
Diniz D
Dev World Bioeth; 2001 Nov; 1(2):153-5. PubMed ID: 12872758
[No Abstract] [Full Text] [Related]
13. Addressing vulnerabilities in developing countries.
Kasturiaratchi ND
Dev World Bioeth; 2001 Nov; 1(2):148-52. PubMed ID: 12872757
[No Abstract] [Full Text] [Related]
14. International patent protection for HIV-related therapies: patent attorney's perspective.
Pavento LC; Greene JL; McDonald JK
Emory Int Law Rev; 2003; 17(2):919-31. PubMed ID: 15199935
[No Abstract] [Full Text] [Related]
15. Market incentives, human lives, and AIDS vaccines.
Craddock S
Soc Sci Med; 2007 Mar; 64(5):1042-56. PubMed ID: 17113203
[TBL] [Abstract][Full Text] [Related]
16. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
17. An HIV vaccine: as we build it, will they come?
McCluskey MM; Alexander SB; Larkin BD; Murguia M; Wakefield S
Health Aff (Millwood); 2005; 24(3):643-51. PubMed ID: 15886155
[TBL] [Abstract][Full Text] [Related]
18. Beyond our borders: different laws, different languages. Universal ethics?
Dhai A; Lavery J
Prot Hum Subj; 2005; (12):15-7. PubMed ID: 16317860
[No Abstract] [Full Text] [Related]
19. Sharing the benefits of HIV/AIDS research with resource-poor countries: AZT for pregnant women in Africa?
Needham DM
Hum Health Care Int; 1997; 13(3):E11. PubMed ID: 14986616
[No Abstract] [Full Text] [Related]
20. Trials and errors: with drug companies now testing new medicines in all parts of the globe, are ethical standards being compromised?
Concar D
New Sci; 2003 Jun; 178(2400):28. PubMed ID: 14686411
[No Abstract] [Full Text] [Related]
[Next] [New Search]
